First Ascent Biomedical's Functional Precision Oncology bridges that gap by testing living tumor cells to generate actionable data in about 10 days, helping physicians choose the right treatment ...

When online platforms violate their own privacy policies to sell your photos, have no fear: They just might have to pay an ...

Advances in DNA sequencing technology help forensic biologists identify suspects where traditional DNA profiling has failed, ...

The study, titled “Managing the ethical risks of AI in intelligence: a multi-layered framework,” published in AI & Society, ...

In this valuable study, the authors develop new approaches to investigate mRNA imprinting, a phenomenon in which RNA-protein complexes form in the nucleus to influence the fate of transcripts in the ...

The platform trial will add new arms testing Enhertu in solid tumors with HER2 amplification and gather data on Tafinlar-Mekinist's tissue-agnostic benefit for regular approval.

Biomarkers are redefining how oncology trials are designed, shifting from single-mutation targeting to comprehensive genomic ...

This Clinical Chemistry and Laboratory Medicine review examines a central challenge in precision medicine: whether medical ...

Aggressive policing tactics like stop-and-frisk are linked to worse newborn health outcomes in neighborhoods where such ...

As a concerned father and a professional in the field, I believe AI safety must be prioritized, and the data layer is the ...